Late acquisition of hyporesponsiyeness to lipopolysaccharide · by Mycobacterium avium-infected human macrophages in producing tumor necrosis factor-α but not interleukin-1β and -6

Journal of Infectious Diseases

Volumn 173, Issue 4, 1996, Pages 1030-1034

  Fattorini, Lanfranco ^b   Xiao, Yan ^b   Ausiello, Clara M ^b   Urbani, Francesca ^b   Lasala, Andrea ^b   Mattei, Maurizio ^b   Orefici, Graziella ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELLULAR IMMUNITY; DISEASE COURSE; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; NONHUMAN; PRIORITY JOURNAL;

GENE EXPRESSION; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; RNA, MESSENGER; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030066689     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.4.1030     Document Type: Article

References (15)

1. Inderlied CB, Kemper CA, Bermudez LEM. The Mycobacterium avium complex. Clin Microbiol Rev 1993;6:266-310.
2. Ellner JJ, Goldberger MJ, Parenti DM. Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution. J Infect Dis 1991;163:1326-35.
3. Meylan PR, Richman DD, Kornbluth RS. Characterization and growth in human macrophages of Mycobacterium avium complex strains isolated from the blood of patients with acquired immunodeficiency syndrome. Infect Immun 1990;58:2564-8.
4. Barrow WW. Contributing factors of pathogenesis in the Mycobacterium avium complex. Res Microbiol 1991;142:427-33.
5. Michelini-Norris MB, Blanchard DK, Pearson CA, Djeu JY. Differential release of interleukin (IL)-1α, IL-1β, and IL-6 from normal human monocytes stimulated with a virulent and an avirulent isogenic variant of Mycobacterium avium-intracellulare complex. J Infect Dis 1992;165:702-9.
6. Shiratsuchi H, Toossi Z, Mettler MA, Ellner JJ. Colonial morphotype as a determinant of cytokine expression by human monocytes infected with Mycobacterium avium. J Immunol 1993;150:2945-54.
7. Fattorini L, Xiao Y, Li B, Santoro C, Ippoliti F, Orefici G. Induction of IL-1β, IL-6, TNF-α, GM-CSF, and G-CSF in human macrophages by smooth transparent and smooth opaque colonial variants of Mycobacterium avium. J Med Microbiol 1994;40:129-33.
8. Furney SK, Skinner PS, Roberts AD, Appelberg R, Orme IM. Capacity of Mycobacterium avium isolates to grow well or poorly in murine macrophages resides in their ability to induce secretion of tumor necrosis factor. Infect Immun 1992;60:4410-3.
9. Barnes PF, Abrams JS, Lu S, Sieling PA, Rea TH, Modlin RL. Patterns of cytokine production by Mycobacterium-reactive human T-cell clones. Infect Immun 1993;61:197-203.
10. Kindler V, Sappino AP, Grau GE, Piguet PE, Vassalli P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989;56:731-40.
11. Gan H, Newman G, McCarthy PL, Remold HG. TNF-α response of human monocyte-derived macrophages to Mycobacterium avium, serovar 4, is of brief duration and protein kinase C dependent. J Immunol 1993;150:2892-900.
12. Gan H, Newman GW, Remold HG. Human macrophages acquire a hyporesponsive state of tumor necrosis factor alpha production in response to successive Mycobacterium avium serovar 4 stimulation. Infect Immun 1995;63:1921-6.
13. Fattorini L, Li B, Piersimoni C, et al. In vitro and ex vivo activities of antimicrobial agents used in combination with clarithromycin, with or without amikacin, against Mycobacterium avium. Antimicrob Agents Chemother 1995;39:680-5.
14. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
15. Ausiello CM, Urbani F, Gessani S, Spagnoli GC, Gomez MJ, Cassone A. Cytokine gene expression in human peripheral blood mononuclear cells stimulated by mannoprotein constituents from Candida albicans. Infect Immun 1993;61:4105-11.